Achieve Life Sciences to appoint three new board directors by April 3 under amended pact with Dialectic

ACHIEVE LIFE SCIENCES, INC.

Amendment to March 1 Cooperation Agreement requires three new Board appointments by April 3, 2023.
Board may expand to up to 11 directors to fill vacancies via incumbent departures or size increase.
New directors will be nominated for election at the 2023 Annual Meeting.
Dialectic Capital Management and affiliates, including John Fichthorn, are parties to the amendment.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ACHIEVE LIFE SCIENCES, INC. amended Amendment to Cooperation Agreement with Dialectic Capital Management, LP and related entities (effective 2023-03-21).

Action: amendment
Counterparty: Dialectic Capital Management, LP and related entities
Effective: 2023-03-21

Exact text from the filing

On March 21, 2023, Achieve Life Sciences, Inc. (the “Company”) entered into an amendment (the “Amendment”) to its Cooperation Agreement (the “Cooperation Agreement”) with Dialectic Capital Management, LP (“Dialectic”) and related entities (collectively with Dialectic, the “Stockholders”) regarding certain changes to the composition of the Company’s board of directors (the “Board”) and other related matters.

View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

ACHIEVE LIFE SCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001564590-23-004277

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.